Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Editas Medicine (EDIT) Assets: 2015-2024

Historic Assets for Editas Medicine (EDIT) over the last 10 years, with Dec 2024 value amounting to $341.6 million.

  • Editas Medicine's Assets fell 38.41% to $201.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $201.8 million, marking a year-over-year decrease of 38.41%. This contributed to the annual value of $341.6 million for FY2024, which is 31.57% down from last year.
  • Latest data reveals that Editas Medicine reported Assets of $341.6 million as of FY2024, which was down 31.57% from $499.2 million recorded in FY2023.
  • In the past 5 years, Editas Medicine's Assets registered a high of $677.5 million during FY2021, and its lowest value of $341.6 million during FY2024.
  • For the 3-year period, Editas Medicine's Assets averaged around $451.7 million, with its median value being $499.2 million (2023).
  • Its Assets has fluctuated over the past 5 years, first grew by 18.32% in 2021, then crashed by 31.57% in 2024.
  • Editas Medicine's Assets (Yearly) stood at $572.6 million in 2020, then rose by 18.32% to $677.5 million in 2021, then dropped by 24.08% to $514.3 million in 2022, then decreased by 2.95% to $499.2 million in 2023, then tumbled by 31.57% to $341.6 million in 2024.